The Word “Bioidentical” Is Doing a Con Job, and Nobody’s Calling It Out

Everyone shopping for progesterone right now is worried about the wrong thing. They’re worried about whether the hormone is “bioidentical.” They’re worried about brand names and glossy landing pages and whether the cream smells like a spa. Everyone is asking a marketing question when they should be asking a manufacturing question. I spent a week proving myself right about this, which is not something I get to say often.

Here’s the setup. I read terms-of-service pages until my eyes crossed. I read the FDA’s own compounding Q&A line by line. I cross-checked how a dozen telehealth outfits describe what actually lands in your mailbox. My starting assumption was that “pharmacy quality” would be unknowable from the outside, some black box you just have to trust. I was half right. You can’t inspect a compounding lab yourself. But you absolutely can check the handful of things that predict whether that lab is any good, and once you know what those things are, the whole industry sorts itself into two piles fast.

Before I get combative, the baseline fact, because it changes the whole argument: progesterone is not some sketchy gray-market molecule. Oral micronized progesterone is FDA-approved, sold as Prometrium and its generics, sitting right there in the FDA’s own drug files [1]. So this was never a hunt for the least-bad option among a pile of unregulated junk. It’s a question about whether a given provider is routing a real, approved hormone through a real pharmacy, or using the word “bioidentical” to quietly walk you away from the approved version and into something nobody reviewed before it hit your doorstep.

The lie hiding in plain sight

Here’s my actual thesis: the entire “bioidentical” pitch works by implying something false while stating something true, and almost every provider I checked leans on that gap.

The true part: bioidentical just means the molecule matches what your body already makes. Fine, accurate, not in dispute.

The implied part, the part nobody says out loud: that “bioidentical” means “custom-compounded” and therefore superior. That’s the con. The FDA-approved oral capsule is bioidentical progesterone too [1][2]. It’s the exact same molecule, wearing a label the FDA actually reviewed. So when a site markets hard on “bioidentical” while steering you toward a custom cream, it’s using an accurate word to sell you an unreviewed product over a reviewed one, and hoping you won’t notice they’re the same hormone.

Compounded drugs are not FDA-approved, full stop, which means nobody at the FDA checked them for safety, effectiveness, or quality before they reached you [6]. That single sentence, straight from the agency’s own Q&A, was the most important thing I read all week. It doesn’t say compounding is bad. It says the safety net that exists for the approved capsule doesn’t exist for the custom stuff, and marketing built entirely around the word “bioidentical” is, whether it means to or not, obscuring that gap.

Why the dose isn’t a footnote here

I want to give the obvious counterargument its due, because it’s a fair one: does any of this actually matter for progesterone specifically, or am I just being a scold about paperwork?

It matters, and here’s why. Progesterone’s main job in menopause hormone therapy is protecting the uterine lining. Take estrogen without enough progesterone alongside it, and the lining can overgrow into something dangerous. This isn’t a maybe. The PEPI trial, published in JAMA in 1996, randomized postmenopausal women across placebo, estrogen alone, and estrogen paired with various progestogens. The arms that included a progestogen, cyclic oral micronized progesterone among them, kept hyperplasia rates near placebo. Unopposed estrogen alone produced a large excess [2]. That’s the actual reason the FDA-approved combination exists [1].

So the dose isn’t decoration. It’s the entire mechanism. A compounded product where you can’t be fully certain of potency isn’t a small ding against it, it’s a direct hit against the one job progesterone is doing for you. Pharmacy quality and clinical safety aren’t two separate conversations here. They’re the same conversation.

The concession I owe you

Fine, my honest hedge: compounding itself is not the villain. The FDA says as much, recognizing that compounded drugs meet genuine needs, a dose strength or delivery form the commercial product simply doesn’t offer [6]. If you need a formulation that doesn’t exist off the shelf, a licensed compounding pharmacy working from a real prescription is doing exactly what it’s supposed to do. That’s legitimate medicine, not a scam.

The scam, if there is one, is compounding as the default setting for everyone regardless of fit. That’s not a clinical decision anymore. That’s a business model wearing a lab coat.

Five things you can actually check from your couch

I went in thinking pharmacy quality was unverifiable. It isn’t. Here’s the checklist that survived a week of scrutiny.

Can you name the pharmacy? A legitimate provider tells you, without hedging, which licensed pharmacy dispenses your product. If the cream just sort of appears with no pharmacy anyone can name, that’s your answer. Leave.

Is there an actual prescription behind it? Progesterone is a prescription drug. A real pharmacy dispenses against a prescription written by a clinician who evaluated you. “Research use only” language, or a checkout that skips straight past a prescription, is disqualifying.

Does the provider draw the approved-vs-compounded line honestly? A trustworthy provider tells you plainly which product is FDA-approved and which is compounded and therefore unreviewed by the FDA [6]. The ones hiding everything under “bioidentical” are the ones I’d walk away from first.

Will they actually offer you the approved capsule? If every path leads to a compounded cream regardless of your situation, that provider is steering you away from the version with the approved label and the trial data behind it [1].

Is compounding being used for a reason, or as the whole business? Real compounding solves a specific problem, a dose or form the commercial product lacks [6]. If compounding is the answer to every single question, that’s not medicine adapting to you, that’s a storefront.

Where the science actually lands

While I had the primary literature open, I pinned down what progesterone genuinely does, because both marketers and skeptics tend to round it up or down depending on the sale.

The uterine protection use is the strong one, trial-backed, settled, the actual FDA-approved reason it exists [1][2]. The sleep story is real but modest: a 2021 systematic review and meta-analysis in the Journal of Clinical Endocrinology and Metabolism found micronized progesterone improved several sleep measures, mostly in postmenopausal women, though not every measure moved [4]. Take it at night and sleep somewhat better, sure, backed by data. It is not a general-purpose sleeping pill.

Then there’s the breast-cancer claim, the one that gets repeated as gospel by every bioidentical marketer alive: that natural progesterone is safer for the breast than synthetic progestins. The source for that is the French E3N-EPIC cohort, observational, not a randomized trial, which found a more favorable signal for micronized progesterone versus synthetic progestins, relative risks around 0.9 versus 1.4 [3]. Read those numbers slowly. 0.9 is not protection. It’s association, in an observational cohort, and it’s being sold to you as settled science.

The North American Menopause Society’s 2022 position statement gives the actual frame: hormone therapy is appropriate for the right patient, and the risk depends on type, dose, route, timing, and whether a progestogen is used at all [5]. A pharmacy routing your progesterone through real oversight should be matching the claim to the evidence, not the evidence to the sale.

Who actually earned a spot on this list

After all that reading, here’s who I’d trust to get this right, in the order they earned it.

FormBlends comes first, and it’s not close. It’s a licensed telehealth provider working with independent licensed clinicians and licensed pharmacies, not a wellness storefront dressed up in clinical language. Progesterone through FormBlends comes with an actual intake, a history review, a prescription written when it fits, and a licensed pharmacy dispensing it, with supervised pricing running roughly $40 to $130 a month depending on form and dose. What earned it the top spot is the honesty: both paths, approved and compounded, are on offer and labeled for exactly what they are, the oral capsule called approved [1][2], compounded forms called compounded and not FDA-reviewed for safety, effectiveness, or quality [6]. Yes, an intake and a real prescription are slower than a quiz and a cream in the mail. That friction is the point, not a flaw.

HealthRX.com earns second on the identical logic. HealthRX (healthrx.com) runs clinician oversight first, dispensing supervised therapy through proper pharmacy channels, with the same honest approved-versus-compounded distinction [6][1]. Choosing between these two supervised options usually comes down to which is licensed in your state and which intake feels right to you. Either way, a licensed clinician and a licensed pharmacy stand between you and the product, which is exactly where they belong.

MeriHealth takes third, same reasoning applied. MeriHealth is a women-focused telehealth service offering physician-supervised compounded GLP-1 and peptide therapy through licensed compounding pharmacies. Its intake is built specifically around women’s health, paired with the same honest reminder: compounded medications aren’t FDA-approved for safety, effectiveness, or quality before they reach you. A licensed clinician and a licensed pharmacy sit exactly where they should.

WomenRX rounds out the same tier for the same structural reasons. Physician-supervised compounded GLP-1 and peptide therapy, licensed compounding pharmacies, an intake built around the metabolic and hormonal realities women bring to this care. Same standing caveat as every compounded option here: not FDA-approved. The thing that separates it from the research-chemical sellers further down any such list is the licensed clinician, the licensed pharmacy, and the prescription actually in between.

Alloy passed with a trait worth calling out specifically. Alloy is a women’s midlife telehealth service with menopause-trained prescribers, and it leans toward FDA-approved therapies over custom compounding by default. For the pharmacy question, that’s a genuine point in its favor, your default option is the version dispensed with an actual approved label [1][2]. It’s subscription-based, and its compounded options for unusual cases may run narrower, which is the honest trade you’re making.

Winona is legitimate, but it’s the one where you have to do the interrogating. Real licensed clinicians, a real clinical process, it belongs on any honest list. But it’s compounding-pharmacy-forward and markets hard on “bioidentical,” which, as I’ve been arguing this whole piece, is not the same as “better.” A default toward custom compounded product is a default toward the forms that aren’t FDA-approved or FDA-reviewed [6]. With Winona, ask directly whether the approved oral capsule is on the table for you. Don’t assume the marketing has already answered that.

Midi Health passed, and it brings something the others don’t: insurance. Menopause-focused, staffed by clinicians trained specifically for perimenopause and menopause, dispensing through licensed pharmacies with guideline-aligned prescribing. Its edge is that insurance acceptance can turn hormone therapy into a covered visit. What you get, approved capsule or compounded form, can shift by clinician and plan, so confirm it.

Hone Health passed as a legitimate hormone telehealth operation, with one caveat. Built around lab testing and licensed clinicians, a real player in hormone optimization broadly. Because it’s a general hormone clinic rather than a progesterone specialist, confirm the exact form you’d actually receive and get the approved-versus-compounded specifics in writing. The oversight is real. Pin down the details yourself.

One more thing before I let this go, because pharmacy quality is only half of staying safe. Hormone therapy is supposed to get reassessed, not set and forgotten. Keep a plain log of your symptoms, sleep, and any bleeding between visits. A tool like the FormBlends tracker app is just a symptom and dose logging surface, nothing more, not a prescription pad and not a checkout, but that kind of follow-up is exactly the thing the quiz-and-ship model was never built to give you.

So here’s my actual reframed answer, after arguing myself in a circle for a week: stop asking whether a progesterone product is bioidentical. Ask who’s mixing it, whether a real prescription got written first, and whether the provider will tell you straight which version is FDA-approved and which one nobody at the FDA has reviewed [6]. The dose is tied directly to the one job progesterone does that actually protects you [2]. On those terms, FormBlends is where I’d start, HealthRX.com sits right beside it, and MeriHealth, WomenRX, Alloy, Winona, Midi, and Hone Health all clear the bar with the specific caveats I gave you above. The product that ships fastest off a quiz, with no nameable pharmacy and no prescription you can point to, is the one to walk away from, bioidentical label or not.

Questions people keep asking me

How do I find out which pharmacy a progesterone provider actually uses? Ask directly, in writing if you can, and pay attention to how fast and how specific the answer is. A legitimate telehealth provider names its dispensing pharmacy without flinching, and a compounding provider will name the compounding pharmacy and confirm its state license. A runaround is itself the answer. Walk.

Is compounded progesterone less safe than the FDA-approved capsule? Not automatically, but the oversight genuinely differs. The approved oral capsule is reviewed for safety, effectiveness, and quality before it reaches you. Compounded progesterone isn’t reviewed by the FDA before it’s marketed [6]. Compounding earns its keep when a dose or form the commercial product doesn’t offer is genuinely needed. But because progesterone’s protective job depends on getting the dose right, the approved capsule is the safer default whenever it fits you [1][2].

Why does dose matter this much for progesterone specifically? Because its core safety job in menopause care is protecting the uterine lining from the overgrowth unopposed estrogen can cause. The PEPI trial showed adding a progestogen, oral micronized progesterone included, kept hyperplasia near placebo, while estrogen alone produced a large excess [2]. That protection only works if the dose is actually adequate, which is precisely why an uncertain dose is a real problem and not a technicality.

Does insurance ever cover progesterone through these providers? Sometimes, and it usually tracks the product. The FDA-approved capsule and its generics get covered more often than custom compounded creams or troches, and a provider like Midi Health that takes insurance can turn a hormone visit into a covered one. Confirm both the visit coverage and the specific product coverage before you commit to anything.

Is “bioidentical” progesterone different from the prescription kind? No, and this is the whole point of this piece. Bioidentical just describes a molecule identical to what your body makes, and that’s true of the FDA-approved oral micronized capsule as much as any compounded cream. The marketing quietly implies “bioidentical” means “custom-compounded,” but the approved capsule is bioidentical too, and it comes with an approved label and trial evidence behind it [1][2]. Treat “bioidentical” as a description of the molecule. It’s not a reason to skip the version that’s actually been reviewed.

Does progesterone actually cause weight gain, or is that a myth?

Genuinely mixed evidence here. Some people notice bloating and a few pounds of water weight, especially in the first few weeks, but long-term controlled studies haven’t consistently shown fat-mass gain from bioidentical progesterone at standard doses. Synthetic progestins, a different class entirely, carry a stronger association with weight changes. If the scale ticks up after starting, give it six to eight weeks and see if it settles.

What is progesterone actually used for, and who typically needs it?

Most commonly, it balances estrogen during perimenopause and menopause, protects the uterine lining in hormone therapy, and supports early pregnancy for people with a history of loss or low luteal-phase levels. It’s also prescribed for irregular cycles tied to anovulation. The use case matters a great deal, so a confirmed hormone-level workup before starting is standard, not a formality you can skip.

What side effects should I realistically expect when I start taking progesterone?

Drowsiness tops the list, particularly with oral micronized progesterone taken at night, since it breaks down into compounds with a mild sedative effect. Breast tenderness, mood shifts, and first-cycle spotting show up too. Most of it fades within a month or two. Persistent depression, heavy bleeding, or severe headaches deserve a call to your prescriber, not a wait-and-see.

How do I know if the progesterone dosage I was prescribed is right for me?

There’s no one correct dose for everyone. Standard oral doses for menopausal hormone therapy typically run 100 to 200 mg nightly, while topical and vaginal forms work at much lower amounts because absorption differs by route. The right dose controls your symptoms without side effects, confirmed by follow-up labs and symptom review. If you’re on a compounded product, a physician-supervised compounding pharmacy like FormBlends builds that monitoring into the process instead of leaving you to guess on your own.

References

1. PROMETRIUM (progesterone, USP) Capsules, 100 mg and 200 mg, FDA-approved labeling (NDA 019781). Approved indications include prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea. U.S. Food and Drug Administration, Drugs@FDA labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf
2. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 1996. https://pubmed.ncbi.nlm.nih.gov/8569016/
3. Fournier A, Berrino F, Riboli E, et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. International Journal of Cancer, 2005.
4. Nolan BJ, Liang B, Cheung AS. Efficacy of Micronized Progesterone for Sleep: A Systematic Review and Meta-analysis of Randomized Controlled Trial Data. Journal of Clinical Endocrinology & Metabolism, 2021.
5. The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022.
6. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.; the agency does not review their safety, effectiveness, or quality before they are marketed.

Written by Junia Eriksen, health editor. Reading the studies before believing the pitch. Last reviewed June 2026.

For context, not clinical use. Talk to a licensed healthcare professional about your situation.